{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T06:31:50Z","timestamp":1791613910460,"version":"4.3.4"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009730","name":"Stand up to Cancer","doi-asserted-by":"publisher","award":["SU2C-AACR-DT1415"],"award-info":[{"award-number":["SU2C-AACR-DT1415"]}],"id":[{"id":"10.13039\/100009730","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016036","name":"Health~Holland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016036","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004622","name":"KWF Kankerbestrijding","doi-asserted-by":"publisher","award":["11809"],"award-info":[{"award-number":["11809"]}],"id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008359","name":"Maag Lever Darm Stichting","doi-asserted-by":"publisher","award":["WO_1901"],"award-info":[{"award-number":["WO_1901"]}],"id":[{"id":"10.13039\/501100008359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008359","name":"Maag Lever Darm Stichting","doi-asserted-by":"publisher","award":["19027"],"award-info":[{"award-number":["19027"]}],"id":[{"id":"10.13039\/501100008359","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ejca.2026.116262","type":"journal-article","created":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T15:49:17Z","timestamp":1769874557000},"page":"116262","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Cancer-associated fibroblast signature and SMAD4 mutation in resistance to adjuvant chemotherapy in stage III colon cancer patients"],"prefix":"10.1016","volume":"236","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0512-6545","authenticated-orcid":false,"given":"Ingrid A.","family":"Franken","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7178-1391","authenticated-orcid":false,"given":"Steven L.C.","family":"Ketelaars","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Rubio-Alarc\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pien","family":"Delis-van Diemen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tessa O.M.","family":"Spaapen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-9918-575X","authenticated-orcid":false,"given":"Floor","family":"Heilijgers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos","family":"da Silva Guimaraes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6763-6519","authenticated-orcid":false,"given":"Sietske C.M.W.","family":"van Nassau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3206-491X","authenticated-orcid":false,"given":"Suzanna J.","family":"Schraa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilma E.","family":"Mesker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2911-6018","authenticated-orcid":false,"given":"Wendy W.J.","family":"de Leng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2112-4390","authenticated-orcid":false,"given":"Onno","family":"Kranenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0330-3130","authenticated-orcid":false,"given":"Gerrit A.","family":"Meijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Koopman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2916-5269","authenticated-orcid":false,"given":"Mark","family":"Sausen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6731-9660","authenticated-orcid":false,"given":"Geraldine R.","family":"Vink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2779-7174","authenticated-orcid":false,"given":"Sanne","family":"Abeln","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2076-5521","authenticated-orcid":false,"given":"Remond J.A.","family":"Fijneman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1398-8970","authenticated-orcid":false,"given":"Jeanine M.L.","family":"Roodhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.ejca.2026.116262_bib1","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.annonc.2020.06.022","article-title":"Localised colon cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up\u2020","volume":"31","author":"Argil\u00e9s","year":"2020","journal-title":"Ann Oncol"},{"issue":"16","key":"10.1016\/j.ejca.2026.116262_bib2","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1200\/JCO.19.00281","article-title":"Duration of oxaliplatin-containing adjuvant therapy for stage III colon cancer: ASCO clinical practice guideline","volume":"37","author":"Lieu","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2026.116262_bib3","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ejca.2020.07.031","article-title":"A new prognostic and predictive tool for shared decision making in stage III colon cancer","volume":"138","author":"Sobrero","year":"2020","journal-title":"Eur J Cancer"},{"issue":"12","key":"10.1016\/j.ejca.2026.116262_bib4","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1001\/jamaoncol.2019.3616","article-title":"Circulating tumor dna analyses as markers of recurrence risk and benefit of adjuvant therapy for stage III colon cancer","volume":"5","author":"Tie","year":"2019","journal-title":"JAMA Oncol"},{"issue":"3","key":"10.1016\/j.ejca.2026.116262_bib5","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1158\/1078-0432.CCR-21-2404","article-title":"Circulating tumor DNA in stage III colorectal cancer, beyond minimal residual disease detection, toward assessment of adjuvant therapy efficacy and clinical behavior of recurrences","volume":"28","author":"Henriksen","year":"2022","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.ejca.2026.116262_bib6","doi-asserted-by":"crossref","first-page":"znaf281","DOI":"10.1093\/bjs\/znaf281","article-title":"Abstract 6559: Circulating tumour DNA in patients with stage III colon cancer: multicentre prospective PROVENC3 study","volume":"113","author":"Alarcon","year":"2026","journal-title":"Br J Surg"},{"key":"10.1016\/j.ejca.2026.116262_bib7","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ejca.2020.11.016","article-title":"Prognostic variables in low and high risk stage III colon cancers treated in two adjuvant chemotherapy trials","volume":"144","author":"Sinicrope","year":"2021","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2026.116262_bib8","unstructured":"Ammendola S., Turri G., Marconi I., Burato G., Pecori S., Tomezzoli A., et al. The presence of poorly differentiated clusters predicts survival in stage II colorectal cancer. doi:10.1007\/s00428-020-02880-y\/Published."},{"issue":"5","key":"10.1016\/j.ejca.2026.116262_bib9","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.amjsurg.2013.02.010","article-title":"Prognostic significance of lymphovascular or perineural invasion in patients with locally advanced colorectal cancer","volume":"206","author":"Huh","year":"2013","journal-title":"Am J Surg"},{"issue":"2","key":"10.1016\/j.ejca.2026.116262_bib10","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41571-020-0422-y","article-title":"Tumour budding in solid cancers","volume":"18","author":"Lugli","year":"2021","journal-title":"Nat Rev Clin Oncol"},{"issue":"4","key":"10.1016\/j.ejca.2026.116262_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2024.102988","article-title":"Results from the UNITED study: a multicenter study validating the prognostic effect of the tumor\u2013stroma ratio in colon cancer","volume":"9","author":"Polack","year":"2024","journal-title":"ESMO Open"},{"issue":"10135","key":"10.1016\/j.ejca.2026.116262_bib12","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/S0140-6736(18)30789-X","article-title":"International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study","volume":"391","author":"Pag\u00e8s","year":"2018","journal-title":"Lancet"},{"issue":"23","key":"10.1016\/j.ejca.2026.116262_bib13","doi-asserted-by":"crossref","first-page":"6531","DOI":"10.1158\/1078-0432.CCR-12-0605","article-title":"Mutation profiling and microsatellite instability in stage II and III colon cancer: an assessment of their prognostic and oxaliplatin predictive value","volume":"18","author":"Gavin","year":"2012","journal-title":"Clin Cancer Res"},{"issue":"3","key":"10.1016\/j.ejca.2026.116262_bib14","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1200\/JCO.2005.01.086","article-title":"Systematic review of microsatellite instability and colorectal cancer prognosis","volume":"23","author":"Popat","year":"2005","journal-title":"J Clin Oncol"},{"issue":"20","key":"10.1016\/j.ejca.2026.116262_bib15","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1200\/JCO.2009.27.1825","article-title":"Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer","volume":"28","author":"Sargent","year":"2010","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.ejca.2026.116262_bib16","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/s41591-020-0805-8","article-title":"Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers","volume":"26","author":"Chalabi","year":"2020","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.ejca.2026.116262_bib17","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1093\/jnci\/djab190","article-title":"KRAS and BRAF mutations in stage II and III colon cancer: a systematic review and meta-analysis","volume":"114","author":"Formica","year":"2022","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"10.1016\/j.ejca.2026.116262_bib18","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1001\/jamaoncol.2015.5225","article-title":"Prognostic effect of BRAF and KRAS mutations in patients with stage III colon cancer treated with leucovorin, fluorouracil, and oxaliplatin with or without cetuximab","volume":"2","author":"Taieb","year":"2016","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ejca.2026.116262_bib19","unstructured":"Guinney J., Dienstmann R., Wang X., De Reyni\u00e8s A., Schlicker A., Soneson C., et al. The consensus molecular subtypes of colorectal cancer. doi:10.7303\/syn2623706."},{"key":"10.1016\/j.ejca.2026.116262_bib20","first-page":"1162","article-title":"Clinical outcome from oxaliplatin treatment in stage II\/III colon cancer according to intrinsic subtypes: Secondary analysis of NSABP C-07\/NRG oncology randomized clinical trial","volume":"2","author":"Song","year":"2016"},{"key":"10.1016\/j.ejca.2026.116262_bib21","article-title":"Benefit of adjuvant chemotherapy on recurrence free survival per consensus molecular subtype in stage III colon cancer","author":"van de Weerd","year":"2024","journal-title":"Int J Cancer"},{"issue":"3","key":"10.1016\/j.ejca.2026.116262_bib22","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/ijc.28387","article-title":"Colorectal cancer intrinsic subtypes predict chemotherapy benefit, deficient mismatch repair and epithelial-to-mesenchymal transition","volume":"134","author":"Roepman","year":"2014","journal-title":"Int J Cancer"},{"issue":"11","key":"10.1016\/j.ejca.2026.116262_bib23","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1080\/0284186X.2016.1189094","article-title":"Prospective Dutch colorectal cancer cohort: an infrastructure for long-term observational, prognostic, predictive and (randomized) intervention research","volume":"55","author":"Burbach","year":"2016","journal-title":"Acta Oncol (Madr)"},{"key":"10.1016\/j.ejca.2026.116262_bib24","doi-asserted-by":"crossref","unstructured":"Casparie M., Tiebosch A.T.M.G., Burger G., Blauwgeers H., Van De Pol A., Van Krieken J.H.J.M., et al. Pathology Databanking and Biobanking in The Netherlands, a Central Role for PALGA, the Nationwide Histopathology and Cytopathology Data Network and Archive. Vol 29. IOS Press Perspective; 2007. www.palga.nl.","DOI":"10.1155\/2007\/971816"},{"key":"10.1016\/j.ejca.2026.116262_bib25","first-page":"i884","article-title":"Fastp: An ultra-fast all-in-one FASTQ preprocessor","volume":"34","author":"Chen","year":"2018"},{"issue":"ement_2","key":"10.1016\/j.ejca.2026.116262_bib26","doi-asserted-by":"crossref","first-page":"ii37","DOI":"10.1093\/bioinformatics\/btae384","article-title":"CIBRA identifies genomic alterations with a system-wide impact on tumor biology","volume":"40","author":"Lakbir","year":"2024","journal-title":"Bioinformatics"},{"issue":"6","key":"10.1016\/j.ejca.2026.116262_bib27","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The molecular signatures database hallmark gene set collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst"},{"key":"10.1016\/j.ejca.2026.116262_bib28","first-page":"i436","article-title":"Comprehensive evaluation of transcriptome-based cell-type quantification methods for immuno-oncology","volume":"35","author":"Sturm","year":"2019"},{"issue":"13_ement","key":"10.1016\/j.ejca.2026.116262_bib29","doi-asserted-by":"crossref","first-page":"3534","DOI":"10.1158\/1538-7445.AM2019-3534","article-title":"Abstract 3534: Analytical performance of a comprehensive genomic profiling system to detect actionable genetic alterations in NSCLC","volume":"79","author":"Gerding","year":"2019","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.ejca.2026.116262_bib30","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1158\/2159-8290.CD-23-0467","article-title":"Quantifying the expanding landscape of clinical actionability for patients with cancer","volume":"14","author":"Suehnholz","year":"2024","journal-title":"Cancer Discov"},{"issue":"D1","key":"10.1016\/j.ejca.2026.116262_bib31","doi-asserted-by":"crossref","first-page":"D980","DOI":"10.1093\/nar\/gkt1113","article-title":"ClinVar: public archive of relationships among sequence variation and human phenotype","volume":"42","author":"Landrum","year":"2014","journal-title":"Nucleic Acids Res"},{"issue":"40","key":"10.1016\/j.ejca.2026.116262_bib32","doi-asserted-by":"crossref","first-page":"5263","DOI":"10.1038\/onc.2016.60","article-title":"Collagen-rich stroma in aggressive colon tumors induces mesenchymal gene expression and tumor cell invasion","volume":"35","author":"Vellinga","year":"2016","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.ejca.2026.116262_bib33","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-023-01860-5","article-title":"Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials","volume":"22","author":"Zhang","year":"2023","journal-title":"Mol Cancer"},{"issue":"16","key":"10.1016\/j.ejca.2026.116262_bib34","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1056\/NEJM200104193441603","article-title":"Molecular predictors of survival after adjuvant chemotherapy for colon cancer","volume":"344","author":"Watanabe","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2026.116262_bib35","unstructured":"Henriksen T.V., Demuth C., Frydendahl A., Nors J., Nesic M., Rasmussen M.H., et al. Title: Timing of circulating tumor DNA analysis aimed at guiding adjuvant treatment in 1 colorectal cancer 2 3. doi:10.1158\/1078-0432.CCR-24-3200\/3545126\/ccr-24-3200.pdf?casa_token=PHhO-kFBI8oAAAAA:QIP_4Wa1QZZyNTfGWA73AJTTikvKm_Y5tPMO0fp89nL0GV8k0zENsC-zyXlHWhkdiI-Nu1Y."},{"key":"10.1016\/j.ejca.2026.116262_bib36","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.23.02262","article-title":"Prognostic models from transcriptomic signatures of the tumor microenvironment and cell cycle in stage III colon cancer from PETACC-8 and IDEA-France trials","author":"Gallois","year":"2025","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2026.116262_bib37","doi-asserted-by":"crossref","first-page":"114207","DOI":"10.1016\/j.ejca.2024.114207","article-title":"Survival and patient-reported outcomes of real-world high-risk stage II and stage III colon cancer patients after reduction of adjuvant CAPOX duration from 6 to 3 months","volume":"208","author":"Franken","year":"2024","journal-title":"Eur. J. Cancer"},{"issue":"4","key":"10.1016\/j.ejca.2026.116262_bib38","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/cas.12096","article-title":"Cancer-associated fibroblast and <scp>M<\/scp> 2 macrophage markers together predict outcome in colorectal cancer patients","volume":"104","author":"Herrera","year":"2013","journal-title":"Cancer Sci"},{"issue":"6","key":"10.1016\/j.ejca.2026.116262_bib39","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1158\/1078-0432.CCR-18-1726","article-title":"Smad4 loss in colorectal cancer patients correlates with recurrence, loss of immune infiltrate, and chemoresistance","volume":"25","author":"Wasserman","year":"2019","journal-title":"Clin Cancer Res"},{"issue":"12","key":"10.1016\/j.ejca.2026.116262_bib40","article-title":"Genetic and microenvironmental evolution of colorectal liver metastases under chemotherapy","volume":"5","author":"Shi","year":"2024","journal-title":"Cell Rep Med"},{"issue":"16_","key":"10.1016\/j.ejca.2026.116262_bib41","doi-asserted-by":"crossref","first-page":"3134","DOI":"10.1200\/JCO.2025.43.16_suppl.3134","article-title":"Combined prognostic value of post-surgery circulating tumor DNA and tumor-stroma ratio in patients with stage III colon cancer treated with adjuvant chemotherapy","volume":"43","author":"Franken","year":"2025","journal-title":"J Clin Oncol"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804926000420?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804926000420?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T16:17:29Z","timestamp":1779380249000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804926000420"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":41,"alternative-id":["S0959804926000420"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2026.116262","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cancer-associated fibroblast signature and SMAD4 mutation in resistance to adjuvant chemotherapy in stage III colon cancer patients","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2026.116262","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"116262"}}